Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.470
-0.030 (-2.00%)
Sep 4, 2026, 11:58 AM CET
Pila Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.26 | 15.9 | 4.89 | 5.95 | 7.24 | 28.21 |
Cash & Short-Term Investments | 3.26 | 15.9 | 4.89 | 5.95 | 7.24 | 28.21 |
Cash Growth | 201.02% | 224.90% | -17.82% | -17.79% | -74.33% | 1379.11% |
Accounts Receivable | - | - | - | 0.05 | - | - |
Other Receivables | 0.14 | 0.14 | 0.07 | 0.23 | 0.2 | 0.15 |
Receivables | 0.14 | 0.14 | 0.07 | 0.28 | 0.2 | 0.15 |
Prepaid Expenses | 0.2 | 0.11 | 0.05 | 0.01 | 0.14 | 0.14 |
Total Current Assets | 3.6 | 16.15 | 5.01 | 6.24 | 7.59 | 28.5 |
Property, Plant & Equipment | - | - | - | - | - | 0.02 |
Long-Term Investments | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
Other Intangible Assets | - | - | 1.08 | 2.15 | 3.23 | 3.23 |
Other Long-Term Assets | 13.2 | - | 0.07 | - | - | - |
Total Assets | 16.86 | 16.22 | 6.22 | 8.46 | 10.89 | 31.81 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.34 | 0.23 | 0.44 | 0.4 | 0.35 | 0.35 |
Accrued Expenses | 0.41 | 0.87 | 0.48 | 0.13 | 0.69 | 0.59 |
Current Income Taxes Payable | - | - | - | 0.13 | 0.13 | 0.04 |
Other Current Liabilities | 0 | 0.47 | 0.04 | 1.14 | 0.19 | 0.53 |
Total Current Liabilities | 0.75 | 1.57 | 0.96 | 1.79 | 1.36 | 1.51 |
Total Liabilities | 0.75 | 1.57 | 0.96 | 1.79 | 1.36 | 1.51 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.95 | 1.8 | 1.16 | 1.02 | 0.79 | 0.69 |
Additional Paid-In Capital | 128.51 | 123.33 | 97.59 | 87.89 | 81.06 | 75.14 |
Retained Earnings | -114.35 | -110.49 | -93.48 | -82.24 | -72.31 | -45.54 |
Shareholders' Equity | 16.11 | 14.65 | 5.26 | 6.66 | 9.53 | 30.3 |
Total Liabilities & Equity | 16.86 | 16.22 | 6.22 | 8.46 | 10.89 | 31.81 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 3.26 | 15.9 | 4.89 | 5.95 | 7.24 | 28.21 |
Net Cash Growth | 201.02% | 224.90% | -17.82% | -17.79% | -74.33% | 1904.68% |
Net Cash Per Share | 0.08 | 0.46 | 0.19 | 0.28 | 0.42 | 2.16 |
Filing Date Shares Outstanding | 45.68 | 42.08 | 27.13 | 23.79 | 18.41 | 16.1 |
Total Common Shares Outstanding | 45.68 | 42.08 | 27.13 | 23.79 | 18.41 | 16.1 |
Working Capital | 2.85 | 14.58 | 4.05 | 4.44 | 6.23 | 26.98 |
Book Value Per Share | 0.35 | 0.35 | 0.19 | 0.28 | 0.52 | 1.88 |
Tangible Book Value | 16.11 | 14.65 | 4.18 | 4.51 | 6.3 | 27.06 |
Tangible Book Value Per Share | 0.35 | 0.35 | 0.15 | 0.19 | 0.34 | 1.68 |
Machinery | - | 0.1 | 0.1 | - | - | 0.1 |